Literature DB >> 18073274

Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.

Brianne S Raccor1, Andreas Vogt, Rachel P Sikorski, Charitha Madiraju, Raghavan Balachandran, Kia Montgomery, Youseung Shin, Yoshikazu Fukui, Won-Hyuk Jung, Dennis P Curran, Billy W Day.   

Abstract

Compounds that bind to microtubules (MTs) and alter their dynamics are highly sought as a result of the clinical success of paclitaxel and docetaxel. The naturally occurring compound (-)-dictyostatin binds to MTs, causes cell cycle arrest in G(2)/M at nanomolar concentrations, and retains antiproliferative activity in paclitaxel-resistant cell lines, making dictyostatin an attractive candidate for development as an antineoplastic agent. In this study, we examined a series of dictyostatin analogs to probe biological and biochemical structure-activity relationships. We used a high-content multiparameter fluorescence-based cellular assay for MT morphology, chromatin condensation, mitotic arrest, and cellular toxicity to identify regions of dictyostatin that were essential for biological activity. Four analogs (6-epi-dictyostatin, 7-epi-dictyostatin, 16-normethyldictyostatin, and 15Z,16-normethyldictyostatin) retained low nanomolar activity in the cell-based assay and were chosen for analyses with isolated tubulin. All four compounds were potent inducers of MT assembly. Equilibrium binding constant (K(i)) determinations using [(14)C]epothilone B, which has a 3-fold higher affinity for the taxoid binding site than paclitaxel, indicated that 6-epi-dictyostatin and 7-epi-dictyostatin displaced [(14)C]epothilone B with K(i) values of 480 and 930 nM, respectively. 16-Normethyldictyostatin and 15Z,16-normethyldictyostatin had reduced affinity (K(i) values of 4.55 and 4.47 muM, respectively), consistent with previous reports showing that C16-normethyldictyostatin loses potency in paclitaxel-resistant cell lines that have a Phe270-to-Val mutation in the taxoid binding site of beta-tubulin. Finally, we developed a set of quantitative structure-activity relationship equations correlating structures with antiproliferative activity. The equations accurately predicted biological activity and will help in the design of future analogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073274     DOI: 10.1124/mol.107.042598

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos.

Authors:  Laura L Vollmer; Maria Jiménez; Daniel P Camarco; Wei Zhu; Hikmat N Daghestani; Raghavan Balachandran; Celeste E Reese; John S Lazo; Neil A Hukriede; Dennis P Curran; Billy W Day; Andreas Vogt
Journal:  Mol Cancer Ther       Date:  2011-04-13       Impact factor: 6.261

Review 2.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

3.  Streamlined syntheses of (-)-dictyostatin, 16-desmethyl-25,26-dihydrodictyostatin, and 6-epi-16-desmethyl-25,26-dihydrodictyostatin.

Authors:  Wei Zhu; María Jiménez; Won-Hyuk Jung; Daniel P Camarco; Raghavan Balachandran; Andreas Vogt; Billy W Day; Dennis P Curran
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

4.  Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol.

Authors:  Ian Paterson; Guy J Naylor; Nicola M Gardner; Esther Guzmán; Amy E Wright
Journal:  Chem Asian J       Date:  2010-10-28

5.  Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts.

Authors:  Julie L Eiseman; Lihua Bai; Won-Hyuk Jung; Gustavo Moura-Letts; Billy W Day; Dennis P Curran
Journal:  J Med Chem       Date:  2008-10-08       Impact factor: 7.446

Review 6.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

7.  Efficient syntheses of 25,26-dihydrodictyostatin and 25,26-dihydro-6-epi-dictyostatin, two potent new microtubule-stabilizing agents.

Authors:  María Jiménez; Wei Zhu; Andreas Vogt; Billy W Day; Dennis P Curran
Journal:  Beilstein J Org Chem       Date:  2011-10-05       Impact factor: 2.883

8.  Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.

Authors:  Xuejian Wang; Fanbo Jing; Huawei Zhu; Hao Fang; Jian Zhang; Wenfang Xu
Journal:  Fundam Clin Pharmacol       Date:  2011-04       Impact factor: 2.748

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.